New data on weight-loss drug; a novel solution to biotech's valuation woes

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: Weight-loss drug had dramatic effect in adolescents with obesity, study finds By Damian Garde Adobe The results will likely widen the use of semaglutide — and fan a debate over whether someone’s body weight should be treated as a disease. Read More STAT+: Novel solution to biotech's market valuation woes: Just give the cash back By Jason Mast and Adam Feuerstein PATRICK T. FALLON/AFP via Getty Images The request, made by Apeiron Investment of the biotech Sensei Biotherapeutics, is a bold response to an industry-wide problem. Read More Opinion: Listen: Will opioid settlement money actually go to opioid prevention? Here's hoping By Patrick Skerrett As states begin to receive money from national opioid settlements, they may not be spending it on efforts that work to prevent addiction. Read More Sponsored Insight by Pan Communications Delivering on the Patient Experience in the Age of Web3 and the Metaverse As patients seek tools to better understand their health and as providers look for ways to optimize care delivery, Web3 sits at the intersection of the entire experience. Whether you serve the needs of pharma, biotech or life science communities, Web3 will push the limits of what we thought possible. How brands tell their story in these new environments will make the difference between staying ahead of the curve or being left behind. Read the full story to begin planning for the future of content marketing and authentic storytelling. CVS, Walgreens announce opioid settlements totaling $10B By Geoff Mulvihill — Associated Press Justin Sullivan/Getty Image The developments could be the last round of huge settlements after years of litigation over the drug industry's role in the overdose epidemic. Read More STAT+: Biotech company seeks to overcome hurdles to develop flu vaccine skin patch By Ryan Cross — The Boston Globe Jessica Rinaldi/Globe Staff The company raised $27 million to test its technology in clinical trials after developing the idea for more than a decade. Read More Wednesday, November 2, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser